To further explore the effect of PCA on GBM in vivo, we administered PCA to GSC1 GBM xenograft growth, and found that PCA treatment significantly restricts GSC1 developed xenograft tumor growth and promotes the survival of mice in situ injected with GSC1 cells (Figure 5G, 5H). This evidence concerns the gene GSC and glioblastoma.